No business profile yet.
Size Ho Tung Chemical (1714.TW) is a Taiwan Materials company (Chemicals: Specialty) with a market value of $388M, the 516th largest of 648 Taiwan companies the cockpit tracks. Shares closed at NT$13.80 on 18 Nov 2026.
Performance Over six months the shares gained 40.2%, against -12.5% for the median peer and -3.4% for the Taiwan market (cap-weighted) — 2nd highest of 21 in its peer set.
Growth Revenue grew 48.2% over the last twelve months (peer median +10.5%); the operating margin is 10.5% (peer median 6.9%).
Valuation It trades at 0.4× enterprise value to sales against a peer median of 2.0× (3rd cheapest of 21).
Price implies For today's price to make sense, revenue must grow about -21% a year for seven years (Req g). Recent delivered growth is -1%, so the hurdle is -19 pp: the price already allows for a slowdown.
Capital Return on invested capital runs 8.6 points above its cost of capital (5.0% WACC).
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Revenue | NT$34.0B | NT$24.0B | NT$20.6B | NT$20.3B | NT$22.6B |
| Revenue growth | — | +17% | +2% | -10% | — |
| Gross profit | NT$4.97B | NT$2.45B | NT$1.71B | NT$1.84B | NT$1.99B |
| EBITDA | NT$4.10B | NT$1.78B | NT$1.51B | NT$1.34B | NT$1.33B |
| Net income | NT$1.42B | NT$490M | NT$415M | NT$599M | NT$370M |
| Free cash flow | NT$844M | NT$802M | NT$1.19B | NT$1.15B | -NT$196M |
| Capital expenditure | NT$387M | NT$313M | NT$255M | NT$383M | NT$488M |
| Total debt | NT$3.82B | NT$3.17B | NT$2.88B | NT$2.95B | NT$3.04B |
The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.
Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.
| Measure | 1714.TW | Peer median | Rank in peer set |
|---|---|---|---|
| 1-month return | -28.3% | -9.9% | lowest of 21 |
| 6-month return | +40.2% | -12.5% | 2nd highest of 21 |
| Distance from 52-week high | -44.8% | -35.1% | 7th lowest of 21 |
| Revenue growth (TTM) | +48.2% | +10.5% | 2nd highest of 21 |
| Operating margin | 10.5% | 6.9% | 8th highest of 21 |
| EV / Sales | 0.4× | 2.0× | 3rd cheapest of 21 |
| Growth the price implies (Req g, 7 yrs) | -20.6% | 16.2% | least demanding of 13 |
| Growth delivered (Del g) | -1.5% | +9.4% | lowest of 13 |
| Hurdle (Req g minus delivered) | -19.2 pp | +4.8 pp | least demanding of 13 |
| ROIC minus cost of capital | +8.6 pp | -3.0 pp | 4th highest of 21 |
| EV / EBITDA | 3.1× | 5.7× | 2nd cheapest of 8 |
| Net debt / EBITDA | -1.5× | 0.3× | 3rd least indebted of 10 |
| Company | Market | Market cap | 6M return | Revenue growth | Op. margin | EV / Sales | Req g | Delivered g |
|---|---|---|---|---|---|---|---|---|
| Ho Tung Chemical 1714.TW | Taiwan | $388M | +40% | +48% | 10% | 0.4× | -20.6% | -1.5% |
| Trust Chem 001335.SZ | China | $388M | -40% | +5% | 7% | 2.0× | 24.6% | +5.6% |
| Zhejiang Hisun Biomaterials 688203.SS | China | $386M | -5% | +47% | 4% | 2.0× | 12.5% | +26.6% |
| Advansix ASIX | United States | $380M | -34% | +8% | -1% | 0.5× | 52.9% | +5.6% |
| Vishnu Chemicals VISHNU.NS | India | $398M | -8% | +14% | 13% | 2.5× | n/a | n/a |
| Luoyang Jianlong Micro-nano New Materials 688357.SS | China | $377M | -25% | +12% | 13% | 2.9× | 7.8% | +13.2% |
| Hubei Shuanghuan Science and Technology 000707.SZ | China | $399M | -11% | -10% | -10% | 1.6× | 56.5% | +3.1% |
| Okura Industrial 4221.T | Japan | $376M | +2% | +19% | 10% | 0.6× | -9.6% | +1.4% |
| Qingdao Copton Technology 603798.SS | China | $401M | -43% | -7% | 5% | 2.2× | 19.9% | +0.9% |
| Shanxi Yongdong Chemistry Industry 002753.SZ | China | $373M | -16% | +18% | 1% | 0.8× | n/a | n/a |
| Zhejiang Haisen Pharmaceutical 001367.SZ | China | $404M | -24% | +9% | 29% | 2.8× | -3.9% | +13.4% |
| KPIC 006650.KS | South Korea | $405M | -40% | +11% | 4% | 0.2× | n/a | n/a |
| Nantex Industry 2108.TW | Taiwan | $370M | -6% | +13% | 13% | 0.3× | n/a | n/a |
| Baotou Dongbao Bio-Tech 300239.SZ | China | $408M | -14% | +7% | 7% | 3.5× | n/a | n/a |
| Oriental Union Chemical 1710.TW | Taiwan | $409M | +41% | +1% | 0% | 1.4× | n/a | n/a |
| Grauer & Weil India GRAUWEIL.NS | India | $367M | +17% | +10% | 13% | 2.8× | 29.0% | +14.6% |
| Guangdong Delian 002666.SZ | China | $410M | -30% | +3% | 0% | 0.6× | n/a | n/a |
| Tatva Chintan Pharma Chem TATVA.NS | India | $412M | +29% | +50% | 13% | 6.2× | n/a | n/a |
| Yangfan New Materials (Zhejiang) 300637.SZ | China | $361M | -9% | +12% | 2% | 2.7× | 24.3% | +13.4% |
| Sakai Chemical Industry 4078.T | Japan | $361M | -7% | +1% | 8% | 0.7× | -2.2% | -0.8% |
| Jinsanjiang (Zhaoqing) Silicon Material 301059.SZ | China | $359M | -34% | +27% | 20% | 4.4× | 7.5% | +18.0% |